D Marmé1. Show Affiliations » 1. Tumor Biology Center, Institute of Molecular Oncology, Freiburg, Germany. marme@tumorbio.uni-freiburg.de
Abstract
Entities: Disease
Mesh: See more » Angiogenesis Inhibitors/therapeutic useAntineoplastic Agents/therapeutic useCell Transformation, Neoplastic/drug effectsGefitinibHumansLung Neoplasms/drug therapyNeoplasms/drug therapyPhthalazines/therapeutic useProtein Kinase Inhibitors/therapeutic useProtein-Tyrosine Kinases/antagonists & inhibitorsPyridines/therapeutic useQuinazolines/adverse effectsQuinazolines/therapeutic useSignal Transduction/drug effects
Substances: See more » Angiogenesis InhibitorsAntineoplastic AgentsPhthalazinesProtein Kinase InhibitorsPyridinesQuinazolinesvatalanibARG tyrosine kinaseProtein-Tyrosine KinasesGefitinib
Year: 2004 PMID: 15148578 DOI: 10.1007/s00120-004-0610-x
Source DB: PubMed Journal: Urologe A ISSN: 0340-2592 Impact factor: 0.639